Surface Pharmaceuticals

Last updated: August 03, 2025
Kamran Hosseini, President & CEO
Kamran Hosseini, President & CEO
Country: USA | Funding: $46.8M (+) | Add Funding

Website: http://surfacepharma.com/

Surface Pharmaceuticals intends to advance state of the art treatments for ocular surface diseases.